Financial advisers have asked for a solution that:
- Offers higher potential returns than the 3-4.5% targeted by most unquoted BR products
-
Leverages Foresight’s long and successful investment track record, institutional strategies and experienced investment team
-
Benefits from 100% IHT relief without investors losing access to or control of their investment, should their circumstances change
We’ve listened…
Please fill in the below form to join the waiting list to hear more.